IGFBP3, insulin like growth factor binding protein 3, 3486
N. diseases: 350; N. variants: 12
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.080 | 7 | 45914866 | missense variant | G/A | snv | 1.1E-02 | 9.9E-03 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
7 | 45914941 | missense variant | C/T | snv | 8.4E-05 | 2.8E-05 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.752 | 0.200 | 7 | 45921046 | missense variant | G/A;C;T | snv | 0.38 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.827 | 0.160 | 7 | 45915430 | intron variant | A/G | snv | 0.58 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 0.080 | 7 | 45914942 | missense variant | G/A;C | snv | 1.6E-05 |
|
Digestive System Diseases; Neoplasms | 0.700 | 0 | ||||||||||
|
0.752 | 0.200 | 7 | 45921046 | missense variant | G/A;C;T | snv | 0.38 |
|
Digestive System Diseases; Neoplasms | 0.050 | 0.400 | 5 | 2007 | 2018 | |||||||
|
0.695 | 0.520 | 7 | 45921476 | intron variant | G/T | snv | 0.48 |
|
Digestive System Diseases; Neoplasms | 0.040 | 0.500 | 4 | 2007 | 2018 | |||||||
|
0.695 | 0.520 | 7 | 45921476 | intron variant | G/T | snv | 0.48 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2007 | 2016 | |||||||
|
0.695 | 0.520 | 7 | 45921476 | intron variant | G/T | snv | 0.48 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2007 | 2016 | |||||||
|
0.695 | 0.520 | 7 | 45921476 | intron variant | G/T | snv | 0.48 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2011 | 2012 | |||||||
|
0.695 | 0.520 | 7 | 45921476 | intron variant | G/T | snv | 0.48 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2011 | 2012 | |||||||
|
0.695 | 0.520 | 7 | 45921476 | intron variant | G/T | snv | 0.48 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2012 | 2018 | |||||||
|
0.752 | 0.200 | 7 | 45921046 | missense variant | G/A;C;T | snv | 0.38 |
|
Pathological Conditions, Signs and Symptoms; Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2010 | 2010 | |||||||
|
0.752 | 0.200 | 7 | 45921046 | missense variant | G/A;C;T | snv | 0.38 |
|
0.020 | 0.500 | 2 | 2010 | 2013 | ||||||||
|
0.925 | 0.080 | 7 | 45921122 | missense variant | T/C | snv | 1.0E-05 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.925 | 0.080 | 7 | 45921122 | missense variant | T/C | snv | 1.0E-05 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.925 | 0.080 | 7 | 45914866 | missense variant | G/A | snv | 1.1E-02 | 9.9E-03 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 1998 | 1998 | ||||||
|
0.925 | 0.080 | 7 | 45914866 | missense variant | G/A | snv | 1.1E-02 | 9.9E-03 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 1998 | 1998 | ||||||
|
0.925 | 0.080 | 7 | 45914866 | missense variant | G/A | snv | 1.1E-02 | 9.9E-03 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 1998 | 1998 | ||||||
|
1.000 | 0.040 | 7 | 45922864 | upstream gene variant | T/A;G | snv |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
1.000 | 7 | 45921946 | upstream gene variant | T/C | snv | 0.79 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 7 | 45921946 | upstream gene variant | T/C | snv | 0.79 |
|
0.010 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
1.000 | 7 | 45921946 | upstream gene variant | T/C | snv | 0.79 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.925 | 0.080 | 7 | 45913974 | intron variant | T/C | snv | 0.26 |
|
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.080 | 7 | 45913974 | intron variant | T/C | snv | 0.26 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2011 | 2011 |